The Department of Health and Hospitals announced on 5 March 2008 Jennifer Kopke's appointment as Assistant Secretary for the Office of Mental Health. For ...
LSU Health Sciences Center Shreveport Announces Schizophrenia Study
03-04-2008
Posted By
Kent B. Payne
by Kent B. Payne
LSU Health Sciences Center-Shreveport’s Psychopharmacology Research Clinic is currently enrolling participants in its CAMP schizophrenia study.CAMP is an acronym for Comparison of Antipsychotics for Metabolic ...
FDA Refuses to Approve Long-Acting Zyprexa Injection
02-28-2008
Posted By
Kent B. Payne
by Kent B. Payne
According to the Wall Street Journal, the FDA cited concerns with “profound sedation” occurring in 1% of patients.The director of FDA’s psychiatric products division noted that the sedation effects ...
Alan Levine, head of Louisiana’s Department of Health and Hospitals since January, states, “In my short tenure, the problem with the mental health system has quickly become the dominating issue. It’s not ...
FDA Panel Recommends Approval of Long-Acting, Injectable Zyprexa
02-19-2008
Posted By
Kent B. Payne
by Kent B. Payne
A long-acting, injectable form of the drug Zyprexa is “acceptably safe” for use in certain schizophrenia patients, a U.S. Food and Drug Administration panel recommended.
